Treatment with the dipeptidyl peptidase-1 inhibitor brensocatib increases the antimicrobial peptide secretory leukocyte peptidase inhibitor (SLPI) in patients with bronchiectasis: results from the WILLOW trial

Lídia Perea, James D. Chalmers, Oriol Sibila et al.|Unknown|2023

Cited by 0